- Rare Disease News
Events Search and Views Navigation
March 2020
Takeda’s Alunbrig Web Event
Speakers: Jason A. Salganick, MD & Larissa C., Patient Ambassador Join us to learn more about ALK+ non-small cell lung cancer (NSCLC) and ALUNBRIG (brigatinib) as a treatment option for ALK+ NSCLC. Hear a healthcare professional speak about ALK+ NSCLC and ALUNBRIG (brigatinib). Hear the story and treatment experience of a person living with ALK+ NSCLC. To register for this webinar, click here. Acknowledgment: This event post is sponsored by Takeda and is promoted through the Patient Worthy Collaborative Content program. We only…
Find out more »April 2020
Takeda’s Alunbrig Web Event
Speakers: Shayma Kazmi, MD, RPh Cancer Treatment Center of America & Danielle, Patient Ambassador Join us to learn more about ALK+ non-small cell lung cancer (NSCLC) and ALUNBRIG (brigatinib) as a treatment option for ALK+ NSCLC. Hear a healthcare professional speak about ALK+ NSCLC and ALUNBRIG (brigatinib). Hear the story and treatment experience of a person living with ALK+ NSCLC. To register for this webinar, visit ALUNBRIGWebEvents.com Acknowledgment: This event post is sponsored by Takeda and is promoted through the Patient…
Find out more »May 2020
Takeda’s Alunbrig Web Event
Speakers: Tarek Mekhail, MD, Advent Health Cancer Institute & Larissa, Patient Ambassador Join us to learn more about ALK+ non-small cell lung cancer (NSCLC) and ALUNBRIG (brigatinib) as a treatment option for ALK+ NSCLC. Hear a healthcare professional speak about ALK+ NSCLC and ALUNBRIG (brigatinib). Hear the story and treatment experience of a person living with ALK+ NSCLC. To register for this webinar, visit ALUNBRIGWebEvents.com Acknowledgment: This event post is sponsored by Takeda and is promoted through the Patient Worthy Collaborative…
Find out more »June 2020
Takeda’s Alunbrig Web Event
Speakers: Viola Zhu, MD, PhD, University of California Irvine & Larissa, Patient Ambassador Join us to learn more about ALK+ non-small cell lung cancer (NSCLC) and ALUNBRIG (brigatinib) as a treatment option for ALK+ NSCLC. Hear a healthcare professional speak about ALK+ NSCLC and ALUNBRIG (brigatinib). Hear the story and treatment experience of a person living with ALK+ NSCLC. To register for this webinar, visit ALUNBRIGWebEvents.com Acknowledgment: This event post is sponsored by Takeda and is promoted through the Patient Worthy…
Find out more »
